Daily non-political popular news in brief.
When it comes to walking, it's all good, says Mayo Clinic researcher
07-11-2007 · EurekAlert!These days, it's easy for people to get confused about exercise -- how many minutes a day should they spend working out, for how long and at what exertion level? Conflicting facts and opinions abound, but one Mayo Clinic physician says the bottom line is this: Walking is good, whether the outcome measurement is blood pressure, diabetes, cardiovascular disease, joint problems or mental health.
Read more »
Keywords: comes, walking, good, mayo, clinic, researcher, come
« Previous | Next »
Similar news on "When it comes to walking, it's all good, says Mayo Clinic researcher":
- Cryoablation continues to show good results for kidney cancer patients
11-25-2007 · EurekAlert!
A review of 62 Mayo Clinic patients who underwent cryoablation to treat cancerous kidney tumors shows that the patients are cancer free for up to two and a half years after having had the procedure.
Similar news · Read more »
- Cryoablation -- A new treatment option for some kidney tumor patients
03-28-2007 · EurekAlert!
Mayo Clinic researchers report that freezing kidney tumors through percutaneous cryoablation shows promise for patients who are not good candidates for surgery.
Similar news · Read more »
- Mayo researcher discovers target site for developing mosquito pesticides
12-20-2006 · EurekAlert!
A Mayo Clinic researcher has discovered a target site within malaria-carrying mosquitoes that could be used to develop pesticides that are toxic to the Anopheles gambiae mosquito and other mosquito species. It would not affect humans and other mammals. If supported by further studies, the findings could offer a safer and more effective control of mosquito-borne diseases such as malaria.
Similar news · Read more »
- Mayo researcher discovers target site for developing mosquito pesticides
12-20-2006 · EurekAlert!
A Mayo Clinic researcher has discovered a target site within malaria-carrying mosquitoes that could be used to develop pesticides that are toxic to the Anopheles gambiae mosquito and other mosquito species.
Similar news · Read more »
- Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
04-15-2007 · EurekAlert!
Mayo Clinic Cancer Center researchers have found that chaetocin, a by-product of a common wood mold, has promise as a new anti-myeloma agent. Results of their study, being presented today at the American Association for Cancer Research annual meeting, show the by-product to be more effective than currently used therapies at killing multiple myeloma cells.
Similar news · Read more »
- How do patients choose the best treatment for their disease?
10-03-2007 · EurekAlert!
The diagnosis has come in, and it's not good. Worse, the patient has to choose from treatment options that are sometimes contradictory and risky. None of them promises complete success. How do patients make an informed decision, choosing the very best treatment for their own healthcare?
Similar news · Read more »
- Take your classroom into space
02-14-2008 · European Space Agency (ESA)
With Europe's Columbus laboratory safely attached to the International Space Station, this is a good time to come up with new ideas for experiments that can be carried out onboard the station to demonstrate the effects of weightlessness to young students.
Similar news · Read more »
- Brief, High-dose Steroid Treatment Offers Extended Relief To Giant Cell Arteritis Patients
10-10-2006 · ScienceDaily
A new study offers both hope and a practical treatment option for patients with giant cell arteritis (GCA). Researchers from Emory University and the Mayo Clinic have found that by treating newly diagnosed GCA patients with just three days of a high-dose intravenous steroid, patients relapsed less in the following year and were able to significantly taper off usage of an oral steroid.
Similar news · Read more »
- Nonminority medical students more satisfied than minority students, study finds
11-09-2006 · EurekAlert!
Minorities account for 30 percent of the U.S. population, but only eight percent of the physician workforce, and experience less personal satisfaction during medical school than nonminority students, finds a Mayo Clinic study published in the November issue of Mayo Clinic Proceedings.
Similar news · Read more »
- Mayo Clinic Cancer Center collaborating to find new tools to fight leukemia
12-10-2006 · EurekAlert!
Mayo Clinic Cancer Center, working in collaboration with Ohio State University Comprehensive Cancer Center, presented evidence Sunday that a novel regimen of three chemotherapy drugs, pentostatin, cyclophosphamide and rituximab, resulted in significant clinical response in patients with previously untreated chronic lymphocytic leukemia (CLL).
Similar news · Read more »
